PDF (15.90 MB) - Boehringer Ingelheim Annual Report 2012

BIBERACH UNIVERSITY OF APPLIEDSCIENCENewly-qualified professionals fromBiberach University of Applied Scienceenter the world of pharmaceuticalbiotechnology.Source: HBCKNOWLEDGE TRANSFER BETWEENACADEMIA AND INDUSTRYSince 2006, a for Germany unique degree course – biopharmaceuticalbiotechnology – has been available at the Biberach University ofapplied sciences, provided in cooperation with, amongst others,Boehringer Ingelheim. The growing importance of pharmaceuticalbiotechnology in economic and research development led to theestablishment of the biotechnology faculty, which in the meantimehas 13 professors and 21 staff.INVESTMENT IN THE FUTURE OFBIOTECHNOLOGYA course of study offering excellentprofessional opportunitesthat supports the region’s strongpharmaceutical industry with ahighly educated new generationof academics – this is the motivationfor strengthened cooperationbetween practice and science,industry and university in the fieldof pharmaceutical biotechnology.The biotechnology cluster Ulm-Laupheim-Biberach-Ravensburg,which is unique in Europe, offersexcellent conditions here.Almost 300 young men and womenare meanwhile studying at the university,with the goal of being able towork, either at home or abroad, inthe many areas of biotechnological,pharmaceutical and biomedical industry.Pharmaceutical biotechnologyThe bachelor of science programmePharmaceutical Biotechnology is specificallyfocused on the developmentand production of biopharmaceuticals.Biberach University held its firstgraduation ceremonies in 2010, witha total of 56 biotechnologists receivingtheir bachelor of science degrees.Additionally, the study course “Industrialbiotechnology” has beenestablished at the university in 2011.Masters degree and doctorateGraduates can now also pursue furtherqualification in their dicipline.In a cooperation with Biberach Universityand Ulm University, a jointmasters programme in pharmaceuticalbiotechnology was established in2010. Based on a good bachelor degreefoundation in, for example,pharmaceutical biotechnology, biochemistryor molecular biology, studentscan receive tuition of a moreresearch-orientated nature.Since 2011, those obtaining an outstandingmasters qualification can alsostudy for a doctorate. A PhD course –pharmaceutical biotechnology – hasbeen established at the University ofUlm and Biberach University.36 Boehringer Ingelheim annual report 2012